THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients.
Zifu YaoAnqi LinYonglin YiWeitao ShenJian ZhangPeng LuoPublished in: Drug design, development and therapy (2022)
THSD7B can be considered a reliable biomarker that effectively facilitates the prediction of poor survival in SCLC platinum-treated patients.